石墨烯又一重磅研究:助力甲状腺结节治疗,拓展临床新应用

2019-04-29 佚名 医谷

石墨烯被誉为“新材料之王”,是目前发现的最薄、强度最大、导电导热性能最强的一种新型纳米材料,是一种由碳原子以sp2杂化方式形成的蜂窝状平面薄膜,具备优良的电学、热学及光学等性能,不仅在涂料、发热散热、供暖、触控等领域实现初步应用,在医疗领域也被视为引发下一次医疗革命的关键。石墨烯治疗“甲状腺结节”重大医疗突破4月28日,由烯旺新材料科技股份有限公司(以下简称:烯旺科技)主办的医疗战略研讨会暨新品发

石墨烯被誉为“新材料之王”,是目前发现的最薄、强度最大、导电导热性能最强的一种新型纳米材料,是一种由碳原子以sp2杂化方式形成的蜂窝状平面薄膜,具备优良的电学、热学及光学等性能,不仅在涂料、发热散热、供暖、触控等领域实现初步应用,在医疗领域也被视为引发下一次医疗革命的关键。

石墨烯治疗“甲状腺结节”重大医疗突破

4月28日,由烯旺新材料科技股份有限公司(以下简称:烯旺科技)主办的医疗战略研讨会暨新品发布会上,发布了一项针对甲状腺结节治疗的石墨烯温热疗法研究成果,结果显示,石墨烯热疗法可缩小良性甲状腺结节的最大直径和最大横截面面积,对甲状腺功能无明显影响,具有良好的应用前景,该研究结果发表在《中国医学物理学杂志》上。 




该研究收纳了来自保定市第一医院体检科检出的甲状腺结节患者共97例(男28例,女69例)。入选标准为年龄≦75岁,超声证实为单发或多发实质性结节,最大结节直径5mm-25mm之间,甲状腺功能在正常范围内。同时,将患者随机分为对照组和治疗组,对照组为47例:年龄(44.19±11.96)岁,体重指数(24.78±3.39)Kg/m2;治疗组50例,年龄(47.94±9.54)岁,体重指数(24.42±2.94)Kg/m2。

研究结果显示,在对治疗组使用石墨烯护颈带进行120天的治疗观察后,对照组对比实验前后的结节最大直径与最大横截面面积,差异无统计学意义(P>O.05),而治疗组的甲状腺最大直径减小0.17±0.13cm,甲状腺结节最大横截面积减小0.41±0.45cm,差异有统计学意义(P<0.05)。

烯旺科技执行董事周云对此表示,“目前,石墨烯在医疗领域的研究刚刚起步,部分停留于理论层面,少数可以实验研究,该项研究证明了石墨烯温热疗法能够弥补甲状腺结节临床无创治疗的空白,是石墨烯行业的重大里程碑式成果,具有广阔的临床应用前景。”

石墨烯展现出巨大的医疗价值

鉴于石墨烯拥有诸多独特的属性,比如更大表面积、生物适应性和化学稳定性等特征,而且石墨烯与人体所发射的远红外光波频率几乎一致,均为6~14μm,可引发远红外共振和非热效应,将远红外热能深层渗透肌体,使其具有极大的研究潜力,在药物传送、癌症治疗、免疫系统生物传感等方面被寄予厚望。

生物传感是一项正在快速发展的新技术,利用石墨烯作为传感器进行体外检测是重要的研究和应用方向。比如,近日在Nanoscale杂志上发表了一项新技术,科学家开发了一种高灵敏度的石墨烯生物传感器,能够尽可能早的识别出特定肺癌标志物。另外,来自德国于利希研究中心、荷兰莱顿大学和中国上海大学的研究人员发现了一种简单的方法来改进石墨烯传感器的灵敏度,因具有非常低的电子噪音而能够检测含量非常低的HIV DNA,该研究发表在Science Advances期刊上。

当然,在药物传送和癌症治疗上,研究人员发现,基于石墨烯更大表面积将大量药物传送至体内,而且其氧化物可作为一种抗癌制剂来对抗特定癌细胞,抑制癌细胞发展速度。同时,石墨烯可以用作免疫组剂,辅助其他药物提高治疗效果,然而这项技术到人体应用仍然有一段很长的距离。此外,石墨烯在人工植入设备中同样扮演着重要角色。目前,石墨烯在3D打印神经组织已取得进展,而且基于其导电性,开发高分子材料培养组织。

烯旺科技董事长冯冠平说到,“石墨烯在医疗市场的应用仍处于早期发展阶段,但其在医疗领域的潜力不可忽视。目前,石墨烯用于体内治疗还存在诸多安全性问题。一旦无法从体内排出,引起病变。现在要做的是鼓励更多的研发项目,以确保将来出现更有效、更持久的预防和治疗方法。”

石墨烯市场巨大,科研助力产生升级

石墨烯新材料,拥有巨大医疗开发潜力。美国伊利诺大学教授、世界自然医学联合会总会副主席陈厚琦教授深度看好石墨烯医疗前景。坚信这种新颖的医疗方式,将为传统医疗思维模式注入新的方向,也为患者带来新的医疗体验。这也同时为未来医疗领域发展开辟了新的可能性。石墨烯医疗时代已经开启,未来还有无限可能。



烯旺科技以石墨烯智能发热为切入口,经过多年研发,以冯冠平教授为首的烯旺科技科研团队开创性发明了改变石墨烯产业格局的纯石墨烯发热膜,实现了石墨烯发热应用领域里程碑式的发展。烯旺科技以纯石墨烯发热膜为技术核心,制定了整套石墨烯智能发热解决方案,成为全球第一家发明石墨烯智能发热穿戴的企业。

“甲状腺结节的医疗战略研究,是烯旺科技发布的一项石墨烯行业程碑式的重大成果,希望在此成果上继续深度研究,将石墨烯发挥更加巨大的价值。自成立以来,烯旺科技始终坚持扎根在石墨烯领域,努力探索如何将这种性能优异的二维材料实现民用化,应用到更广泛的领域,开发出更多的潜能。成立短短4年的时间里,创造了石墨烯应用的一个又一个迈进。我们首次将石墨烯应用到发热领域,第一款智能穿戴应用,石墨烯从实验室走向民用领域。自主研发发热服登上平昌冬奥会,中国石墨烯技术推向了世界前沿。未来,烯旺科技将不断专注科研,继续开辟医疗健康的新应用。”烯旺科技董事长冯冠平介绍。

据悉,在此次发布会上烯旺科技宣布烯时代纯石墨烯护肩、护腰、护膝即将获得国家二类医疗器械证书,这代表着烯旺科技进入医疗领域,石墨烯打开了医疗领域的大门。同时,烯旺科技并购格菲电子,这也标志着烯旺科技正式进入石墨烯产业链上游,成为集研发、原材料加工、投资、设计、生产、制造及销售为一体的石墨烯全产业、全价值链企业。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2021-09-02 1477ab07m21暂无昵称

    期待研究成果

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2020-09-14 ms4000000688077394

    感谢各位老师为大家的健康付出艰辛的努力!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-10-06 jyzxjiangqin

    甲状腺结节的治疗。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-06-30 jyzxjiangqin

    石墨烯的影响。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-06-19 jyzxjiangqin

    石墨烯的影响。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-05-26 jyzxjiangqin

    助力甲状腺结节治疗。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-05-02 jyzxjiangqin

    助力甲状腺结节治疗。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-05-01 xxxx1054
  10. [GetPortalCommentsPageByObjectIdResponse(id=1013649, encodeId=82051013649df, content=期待研究成果, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3815220226, createdName=1477ab07m21暂无昵称, createdTime=Thu Sep 02 07:59:02 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=885202, encodeId=3bf8885202fa, content=感谢各位老师为大家的健康付出艰辛的努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11495418198, createdName=ms4000000688077394, createdTime=Mon Sep 14 16:46:09 CST 2020, time=2020-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1651584, encodeId=1ad216515845c, content=<a href='/topic/show?id=6e78e32573c' target=_blank style='color:#2F92EE;'>#石墨烯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73257, encryptionId=6e78e32573c, topicName=石墨烯)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8db924213398, createdName=yangjxjc, createdTime=Fri Aug 02 09:02:00 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373590, encodeId=94463e359037, content=甲状腺结节的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Oct 06 17:41:22 CST 2019, time=2019-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368656, encodeId=7631368656a2, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Jun 30 11:33:35 CST 2019, time=2019-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368006, encodeId=1a05368006e6, content=石墨烯的影响。, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed Jun 19 10:23:54 CST 2019, time=2019-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=366810, encodeId=7cd33668108f, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 26 09:02:13 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365607, encodeId=04eb36560e1e, content=助力甲状腺结节治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu May 02 10:53:15 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549467, encodeId=c2b2154946e14, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Wed May 01 14:02:00 CST 2019, time=2019-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365490, encodeId=848536549014, content=学习了,涨知识了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDM9swhbgTo7nzqRKzMmzckmEoeTyLQVDCgjqsicjyhxPs0vPoYU6GsSYbCjSkNHicJkz3NL0a0EbUMVdNjkctXI6FocpGKaVr9E/0, createdBy=29392048316, createdName=王秀, createdTime=Mon Apr 29 23:16:12 CST 2019, time=2019-04-29, status=1, ipAttribution=)]
    2019-04-29 王秀

    学习了,涨知识了!

    0

相关资讯

Interface Focus:石墨烯-聚(甲基丙烯酸甲酯)纤维对微生物生长的影响

本研究旨在探究一类新型超薄纤维对微生物生长的作用。研究了含有2、4和8 wt%石墨烯纳米片(GNP)的聚(甲基丙烯酸甲酯)纤维的微生物特性。将GNPs分散在聚合物溶液中并使用加压回转进行处理。电子显微镜用来表征GNP和纤维形态。扫描电子显微镜显示珠状多孔纤维的形成。研究发现GNP的浓度决定纤维的形态。随着GNP浓度的增加,纤维平均直径从0.75增加到2.71μm,而纤维孔隙率下降。使用革兰氏阴性菌

Adv Sci:基于石墨烯的miRNA转染可阻断前粘连蛋白融合增加骨形成和血管形成

本研究旨在设计一种石墨烯基miRNA转染药物递送系统用于抗吸收治疗。使用负载有miR-7b过表达质粒的聚乙烯亚胺(PEI)功能化的氧化石墨烯(GO)复合物开发了高效的非病毒基因递送系统。GO-PEI复合物在可接受的细胞毒性范围内表现出优异的转染效率。GO-PEI-miR-7b转染后miR-7b的过表达通过阻碍基本促融合分子树突细胞特异性跨膜蛋白的表达明显消除破骨细胞(OC)融合和骨吸收活性。然而,

Small:甘草次酸功能化氧化石墨烯可靶向线粒体用于癌症的治疗

由于线粒体内存在细胞自杀因子,因此线粒体介导的细胞凋亡(MMA)癌症治疗的优先选择,但线粒体低通透性则成了靶向药物递送的瓶颈。本研究中,研究人员发现光果甘草天然产物甘草次酸(GA)是一种新型的线粒体靶向配体,可以提高线粒体的通透性,增加线粒体对药物的摄取。首先制备GA功能化的氧化石墨烯(GO),然后将其用作靶向递送阿霉素进入线粒体的载体。体外和体内机制研究表明,GA功能化的GO可降低线粒体膜电位并

J Environ Sci:四环素和石墨烯纳米材料在水溶液中的相互吸附作用

了解水溶液中石墨烯纳米材料(GNMs)与抗生素之间的相互作用对于GNMs的工程应用以及评估其对水生环境中抗生素的结局和运输的潜在影响至关重要。在本研究中,研究人员使用多壁碳纳米管(MWCNTs)和石墨作为对照,检测氧化石墨烯(GO)和还原氧化石墨烯(RGO)对一种常见抗生素四环素的吸附。 结果表明,四种选择的含碳材料在单位质量基础上的四环素吸附容量遵循GO> RGO> MWCNT

Sci Adv:只用石墨烯和光控制心脏,实现不同跳动频率!

最近在《 Science Advances》杂志发表的一项研究成果中, 科学家们想出了如何用光和石墨烯对人类心脏细胞进行实验,从而在实验玻璃皿中模拟心脏跳动的环境。目前为止, 所有正在开发中的药物都需要在心脏细胞上进行实验测试, 以确保诸如止痛药导致心脏病发作等事故不会发生。实验中,这些心脏细胞会在实验玻璃皿或塑料实验皿中培养生长。但是这样的实验环境与实际的心脏跳动有一个很大的区别,那就是,玻璃和

J Biomed Mater Res A:石墨烯结构作为骨组织工程骨诱导因子的体外效应

众所周知,石墨烯及其衍生物可影响干细胞/祖细胞向成骨细胞谱系分化。然而,关于石墨烯参数对骨再生的影响,包括石墨烯浓度、尺寸、类型、亲水性、官能化和组成等方面,在文献中存在许多争议。本研究旨在给定参数及其对刺激细胞行为如增殖、存活力、附着和成骨分化的影响进行全面综述。在这项研究中,研究人员系统搜索了MEDLINE数据库中体外研究使用石墨烯及其衍生物进行骨组织工程的相关研究,时间设定为2000年1月至